Renub Research

Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global

Press Release   •   Dec 09, 2013 05:34 EST

Cancer is the second-leading cause of death and disability in the world, behind only heart disease. More people die from cancer every year around the world than AIDS, Tuberculosis and Malaria combined. Cancer testing has tremendous growth opportunities for the next five years. According to the National Cancer Institute (NCI), 85% of cancer patients are treated in community-based, private practice oncology settings. Accordingly, global expansion of cancer marker technologies may be fueled by an increased marketing of new diagnostic tests to physicians. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. The anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The global cancer test market is expected to be more than US$ 14 Billion by 2018. 
Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. 
A. Global – Cancer Testing Market and New Cases (Chapter 2) B. Global – Cancer Testing Market Share & Forecast (Chapter 3) C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4) D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5) E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6) F. Geographic Region – Number of New Cancer Cases (Chapter 7)G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8)
Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4) 
• Prostate Specific Antigen (PSA) Test Market & Forecast• Fecal Occult Blood Test Market & Forecast• Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast• Human Papilloma Virus (HPV) Test Market & Forecast• Bladder Test Market & Forecast• Serum Based Cancer Markers Market & Forecast• Pharmacognostic Histology Market & Forecast• Flow Cytometry  Market & Forecast• Other Test Market & Forecast
Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5) 
• Bladder Cancer Test Market & Forecast• Breast Cancer Test Market & Forecast• Cervical Cancer Test Market & Forecast • Colorectal (Colon) Cancer Test Market & Forecast• Ovarian Cancer Test Market & Forecast• Prostate Cancer Test Market & Forecast• Liver Cancer Test Market & Forecast• Flow Cytometry  Market & Forecast• Other Organ Specific Cancer Test Market & Forecast
 Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6) 
1 Abbott                        11 Genomic Health Inc2 Radient Pharmaceuticals 12 QIAGEN Marseille (Earlier Ipsogen) 3 BD Diagnostics                13 Myriad Genetics, Inc4 Beckman Coulter, Inc.        14 Panacea Pharmaceuticals, Inc.5 BioCurex                15 Qiagen6 bioMerieux                16 Siemens Heathcare Diagnostics7 Cepheid                        17 Roche 8 CytoCore Inc.                   18 Ventana Medical Systems9 DiagnoCure, Inc               19 Trovagene Inc10 Gen-Probe, Inc.                 20 Vermillion, Inc

Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7) 
 1. Africa2. Americas3. Asia4. Europe5. Oceania 
Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8)
1 Bladder Cancer         15 Myeloma2 Brain Cancer         16 Nasopharynx3 Breast Cancer         17 Non-Hodgkin Lymphoma4 Cervix Cancer         18 Oesophagus 5 Colorectal Cancer 19 Oral Cavity 6 Corpus Cancer         20 Other Pharynx 7 Hodgkin’s Lymphoma 21 Ovary Cancer 8 Kaposi Sarcoma         22 Pancreas Cancer9 Kidney Cancer         23 Prostate Cancer10 Larynx Cancer         24 Stomach Cancer11 Leukaemia         25 Testis Cancer12 Liver Cancer         26 Thyroid Cancer13 Lung Cancer         27 Other Sites14 Melanoma
Cancer Site - Clinical Trials (Chapter 8)
 1. Bladder Cancer2. Cervical Cancer3. Colorectal Cancer4. Liver Cancer 5. Ovarian Cancer 6. Prostate Cancer 

Data Sources
 This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Renub Research team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.

Click here to view the report details: http://www.renub.com/report/cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials---global-125
For more information visit: http://www.renub.com/


Contact Us
Andy HillSr. Manager - Publisher RelationSales & Marketing DivRenub ResearchEmail: info@renub.com Phone:  +1-678-302-0700 (USA) +91-120-254-5750 (India)Web: http://www.renub.com/

Renub Research is a Management Consultancy and Information Analysis Company with centers at Noida, India and Roswell, USA. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others